Sectors
OSTX
OS Therapies Incorporated
1.69
1700 x 1.68
2300 x 1.69
bid
ask
+
0.05
3.05%
2000 @ 07:30 PM
1.70 +0.01 (0.59%)
| Ytd | 20.71% | |
| 1y | -29.29% |
1.62
day range
1.69
1.15
52 week range
2.36
| Open | 1.62 | Prev Close | 1.64 | Low | 1.62 | High | 1.69 | Mkt Cap | 78.54M |
| Vol | 234.96K | Avg Vol | 591.07K | EPS | -1.12 | P/E | N/A | Forward P/E | 2.57 |
| Beta | -0.73 | Short Ratio | 1.22 | Inst. Own | 0.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 1.64 | 200-d Avg | 1.59 | 1yr Est | 12.67 |
| Income Statement | |||
| Operating Expenses | 8.58M | ||
| Research and Development Expense | 6.07M | ||
| Selling, General and Administrative Expense | 2.50M | ||
| Operating Income | -8.58M | ||
| Interest Expense | 5.58K | ||
| Net Income | -8.63M | ||
| Net Income Common Stock | -8.63M | ||
| Net Income Common Stock (USD) | -8.63M | ||
| Consolidated Income | -8.63M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -8.63M | ||
| Earning Before Interest & Taxes (USD) | -8.63M | ||
| Weighted Average Shares | 43.90M | ||
| Weighted Average Shares Diluted | 43.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 205.04K | ||
| Cash and Equivalents (USD) | 205.04K | ||
| Current Assets | 3.64M | ||
| Property, Plant & Equipment Net | 1.10K | ||
| Total Assets | 9.90M | ||
| Current Liabilities | 20.64M | ||
| Total Liabilities | 20.74M | ||
| Accumulated Retained Earnings (Deficit) | -86.22M | ||
| Shareholders Equity | -11.91M | ||
| Shareholders Equity (USD) | -11.91M | ||
| Assets Non-Current | 6.26M | ||
| Goodwill and Intangible Assets | 6.26M | ||
| Liabilities Non-Current | 100.00K | ||
| Trade and Non-Trade Payables | 20.62M | ||
| Tax Assets | 3.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 124.94K | ||
| Net Cash Flow from Financing | 4.82M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -712.52K | ||
| Issuance (Purchase) of Equity Shares | 4.82M | ||
| Net Cash Flow from Operations | -5.53M | ||
| Share Based Compensation | 1.33M | ||